Myriad Genetics Inc
MYGN· Nasdaq
MYGNMyriad Genetics Inc
Source filing unavailable
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $100.44M | $92.77M |
| Net Income | $24.19M | $35.36M |
| EPS Diluted | $0.26 | $0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
